Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDe La Rue Regulatory News (DLAR)

  • This share is currently suspended. It was suspended at a price of 130.00
  • There is currently no data for DLAR

Trading Statement

13 Apr 2021 07:00

RNS Number : 2105V
De La Rue PLC
13 April 2021
 

13 April 2021

DE LA RUE PLC

TRADING UPDATE

De La Rue plc (LSE: DLAR) ("De La Rue" or the "Company") today announces a trading update for financial year 2020/21, which ended 27 March 2021.

 

As a result of continued positive trading, the Board expects Adjusted Operating Profit for the financial year 2020/21 to be around the top end of the £36 million to £37 million range previously indicated in the Company's trading update of 28 January 2021.

End of year Net Debt was approximately £53 million, which is lower than market expectations(1) by approximately £21 million. This is mainly due to lower capital expenditure during the year, consistent with adjustments made to the timing of capital spend as the Turnaround Plan has evolved. Total aggregate 3-year cash investment for the Turnaround Plan remains unchanged.

Due to the positive outcome of the financial year, the Company has repaid all the money received from HM Government's Coronavirus Job Retention Scheme. Furlough payments received under this scheme totalled approximately £0.4m.

In the results for financial year 2020/21, the Company will record non-cash exceptional asset impairment and accelerated depreciation charges of approximately £13 million on historic assets, as a result of the closure of the Gateshead banknote printing operations in December 2020. Of this, approximately £12m was recorded in the second half of the year following finalisation of the detailed plans for which assets currently are expected to have any ongoing use within the group.

De La Rue expects to announce its results for the full year ended 27 March 2021 on 26 May 2021.

De La Rue plc's LEI code is 213800DH741LZWIJXP78.

(1). Market expectations are based on the average of published notes from Investec and Numis Securities.

Enquiries:

 

De La Rue plc

 

+44 (0) 7387 122645

Clive Vacher

 

Chief Executive Officer

Rob Harding

 

Chief Financial Officer

Matthew Rose

 

Director of Tax, Treasury and Investor Relations

 

Brunswick Group LLP +44 (0)207 404 5959

Stuart Donnelly/Ed Brown

 

 

Cautionary note regarding forward-looking statements

 

This announcement includes statements that are, or may be deemed to be, "forward-looking statements". These forward-looking statements can be identified by the use of forward-looking terminology, including the terms "believes", "estimates", "anticipates", "expects", "intends", "plans", "may", "will", "could", "shall", "risk", "aims", "predicts", "continues", "assumes", "positioned" or "should" or, in each case, their negative or other variations or comparable terminology. These forward-looking statements include all matters that are not historical facts. They appear in a number of places throughout this announcement and include statements regarding the intentions, beliefs or current expectations of the directors, De La Rue or the Group concerning, amongst other things, the results of operations, financial condition, liquidity, prospects, growth and strategies of De La Rue and the industry in which it operates.

By their nature, forward-looking statements involve known and unknown risks, uncertainties, assumptions and other factors because they relate to events and depend on circumstances that will occur in the future whether or not outside the control of the Company. Past performance cannot be relied upon as a guide to future performance and should not be taken as a representation or assurance that trends or activities underlying past performance will continue in the future. Accordingly, investors or potential investors should not place undue reliance on these forward-looking statements. The Group's actual results of operations, financial condition, liquidity and the development of the industry in which it operates may differ materially from the impression created by the forward-looking statements contained in this announcement. In addition, even if the results of operations, financial condition and liquidity of the Group and the development of the industry in which it operates, are consistent with the forward-looking statements contained in this announcement, those results or developments may not be indicative of results or developments in subsequent periods.

Other than in accordance with its legal or regulatory obligations, De La Rue does not undertake any obligation to update these forward-looking statements, which speak only as at the date of this announcement, and will not publicly release any revisions that may be made to these forward-looking statements, which may result from events or circumstances arising after the date of this announcement.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTITMRTMTBBBFB
Date   Source Headline
23rd Nov 20227:00 amRNS2022/23 HALF YEAR RESULTS
22nd Nov 202210:39 amRNSHolding(s) in Company
10th Nov 20227:00 amRNSResponse to Crystal Amber's open letter
3rd Nov 20222:33 pmRNSNotice of GM
27th Oct 20221:00 pmRNSDE LA RUE PLC ANNOUNCES GENERAL MEETING
30th Sep 20224:41 pmRNSSecond Price Monitoring Extn
30th Sep 20224:35 pmRNSPrice Monitoring Extension
23rd Sep 20227:00 amRNSExtension of contract
13th Sep 202210:58 amRNSDirectorate Change
2nd Sep 20227:00 amRNSExecutive Changes in Authentication Division
1st Sep 202212:10 pmRNSDirector/PDMR Shareholding
10th Aug 20221:55 pmRNSDirector/PDMR Shareholding
1st Aug 202210:01 amRNSTotal Voting Rights
27th Jul 202211:53 amRNSResult of AGM
26th Jul 20225:11 pmRNSTERMINATION OF RELATIONSHIP AGREEMENT WITH PORTALS
11th Jul 20227:00 amRNSDirector/PDMR Shareholding
6th Jul 20221:47 pmRNSDirector/PDMR Shareholding
1st Jul 202210:46 amRNSBlock listing Interim Review
1st Jul 202210:40 amRNSTotal Voting Rights
24th Jun 202210:21 amRNSAnnual Financial Report
9th Jun 20221:38 pmRNSHolding(s) in Company
31st May 20229:25 amRNSHolding(s) in Company
25th May 20227:00 amRNSFY22 Full Year Results
23rd May 20221:03 pmRNSAdditional Listing
7th Apr 20227:00 amRNSTrading Update
1st Apr 202210:17 amRNSTotal Voting Rights
18th Mar 20227:00 amRNSUpdate on Responsible Business Activities
11th Mar 202210:45 amRNSHolding(s) in Company
3rd Mar 20227:00 amRNSPension Scheme funding update
1st Mar 202210:44 amRNSTotal Voting Rights
3rd Feb 20227:00 amRNSAuthentication Contract Win
1st Feb 20229:44 amRNSTotal Voting Rights
26th Jan 20222:46 pmRNSHolding(s) in Company
24th Jan 20227:00 amRNSTrading and Turnaround Plan Update
12th Jan 20225:48 pmRNSChange in Director's Particulars
5th Jan 20224:37 pmRNSDirector/PDMR Shareholding
4th Jan 202212:06 pmRNSBlock listing Interim Review
4th Jan 202212:02 pmRNSTotal Voting Rights
1st Dec 202111:59 amRNSTotal Voting Rights
24th Nov 20217:00 amRNS2021/22 HALF YEAR RESULTS
1st Nov 202111:55 amRNSTotal Voting Rights
15th Oct 202110:08 amRNSHolding(s) in Company
12th Oct 20217:00 amRNSTrading Statement
1st Oct 20212:24 pmRNSTotal Voting Rights
15th Sep 20217:00 amRNSAnnouncement Of Significant Expansion In Malta
1st Sep 202111:00 amRNSTotal Voting Rights
4th Aug 202111:30 amRNSHolding(s) in Company
2nd Aug 20219:58 amRNSTotal Voting Rights
29th Jul 20211:36 pmRNSResult of AGM
29th Jul 20217:00 amRNSAGM Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.